2nd Mar 2011 13:31
Estate agent and surveyor LSL Property Services said it is cautious on the market for 2011 given the shortage of mortgage finance and other economic challenges but confident it can continue gaining market share. For the year to 31 December, revenue at LSL, which operates Britain's biggest estate ag
Read more1st Feb 2011 13:08
Search software provider Autonomy Corporation is higher even though it reported a fall in fourth quarter profit. Profit in the three months to December 2010 came in at $88.4m, down from $95.8m last time, on revenues of $244.5m up from $223m. Broker Peel Hunt is cautious about Autonomy's future.
Read more12th Jan 2011 12:55
Shares in Promethean World reacted positively after it revealed that it is cutting more costs. The e-learning group says that 2010 revenues will be near to the top of downgraded expectations. Management expects trading to continue to be tough. There will be higher than expected one-off costs at the
Read more20th Dec 2010 11:59
Oxford Biomedica is continuing to decline following last Monday's announcement of its £20m placing and open offer at 5p a share. The share price has fallen by nearly one-third since 10 December. In contrast, NXT has risen 18% in the past week. This follows the announcement of the proposed appointm
Read more14th Dec 2010 11:05
Chipmaker Imagination Technologies is higher on the day after interim revenue rose 16% to £44m. Adjusted pre-tax profit surged to £10.1m as chip unit volumes doubled and licensing revenues increased. Imagination is buying Caustic Graphics for $27m, which will enable it to bring 3D graphics to mob
Read more13th Dec 2010 16:33
More than £2bn of merger and acquisition activity got pulses racing in City dealing rooms, combining with strong miners and gains on Wall Street to send London to its highest in a month. Oilfield services group Wood Group is forking out $955m (£607m) for rival PSN, which it will merge with its prod
Read more13th Dec 2010 13:11
Oxford Biomedica intends to raise up to £20m at a significant discount to Friday's closing price. The gene-based therapies developer is offering existing shareholders the opportunity to subscribe for two new shares for every nine they hold at 5p a share. The rest of the cash will come from a firm
Read more13th Dec 2010 10:24
African Copper rallied again today, up to a nine-month high, forcing the miner to confirm it has received an interim mining licence for the Thakadu deposit in Botswana. "The grant of the full mining licence is pending further discussion and agreement with the government of Botswana," it said Mond
Read more9th Nov 2010 12:45
Highland Gold has started mining at its Belaya Gora open pit. Select oxide ores will be hauled to and processed as planned at the Mnogovershinnoye. This marks the initial production at Highland Gold's third producing mine. Oxford BioMedica has received approval from the US Food and Drug Administrat
Read more9th Nov 2010 12:15
ProStrakan shares have jumped following the announcement yesterday evening that Norgine had acquired a 12.6% stake. Norgine has said that it has no current intention of making an offer for the Scotland-based speciality pharmaceuticals company. Privately-owned Norgine is more than one hundred yea
Read more29th Oct 2010 12:54
Shares in gene therapy developer Oxford Biomedica have edged down even though it said that it expects six of its products to commence clinical trials next year. Net cash has reduced by £2.6m to £13.7m in the three months to September 2010. That cash should last until the beginning of 2012.
Read more28th Sep 2010 14:04
Accounting software supplier Sage continues to move higher on bid rumours. Capgemini has been suggested as a potential bidder. Psion is higher after it launched its first modular device, the Psion Omii XT10. Two automatic trades after 1pm sent Oxford Biomedica lower. The first was the sale of 9
Read more22nd Sep 2010 12:33
Oxford Biomedica is higher after its TroVax vaccine was chosen as one of the 10 oncology projects to watch by Windhover Information and the publishers of In Vivo and Start Up industry publications. TroVax is designed to stimulate the immune system to destroy cancer cells. A phase II study for the t
Read more26th Jul 2010 16:00
Dow Jones smallcap news is now on Twitter, allowing you to catch up on the news away from your desk. Go to http://twitter.com/DJ_UK_Smallcaps INTEC TELECOM SYSTEMS PLC (ITL.LN), a billing software company, Monday said it is in very early discussions that may or may not lead to an offer for the
Read more26th Jul 2010 13:39
Oxford Biomedica, which has traded between 9.10p and 12p all year, bounced off the lower end of its trading range on Monday after the gene therapy company announced significant regulatory approval for its TroVax drug. The US Food and Drug Administration (FDA) and Recombinant DNA Advisory Committee
Read more